Core Viewpoint - The company is closely monitoring developments in the international small nucleic acid field and is tracking the application progress of small nucleic acid drugs [1] Group 1: Core Business Focus - The company's core business is focused on the research, development, production, and sales of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates [1] - Key products include sodium cytidine diphosphate, ribavirin, cytarabine hydrochloride, and cytosine, which are widely used in antiviral, antitumor, and neurological medications [1] Group 2: Health and Functional Food Market - The company is actively expanding into the health functional food raw material market, with main products including L-α-glycerophosphocholine, coenzyme Q10, monohydrate creatine, and L-carnitine [1] Group 3: Future Strategy - The company plans to closely follow market demand changes and continuously increase R&D investment to enhance operational performance and intrinsic value [1]
拓新药业：公司核心业务聚焦于原料药及医药中间体的研发、生产与销售